KIMBERLY HALL: Open Payments
NPI 1376089318 · CONROE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,509 in 77 payments from 23 companies in 2025. Trend: 2023 $2,902 · 2024 $1,918 · 2025 $1,509
Food & beverage: $1,509
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $363 |
| Novo Nordisk Inc | 11 | $240 |
| Lilly USA, LLC | 9 | $143 |
| Medtronic, Inc. | 2 | $96 |
| AstraZeneca Pharmaceuticals LP | 3 | $64 |
| Dexcom, Inc. | 3 | $59 |
| Exact Sciences Corporation | 3 | $58 |
| Amgen Inc. | 3 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $50 |
| GlaxoSmithKline, LLC. | 3 | $44 |
Products named: VRAYLAR, QULIPTA, Wegovy, MOUNJARO, SIGNIA, Ozempic, Dexcom G6 Transmitter, Cologuard Collection Kit.
Industry payments across TX — which companies pay providers there.
